Molds-Broth Microdilution Testing (EUCAST): Introduction, Principle, Clinical Significance, and Keynotes

Introduction

Invasive mold infections caused by species such as Aspergillus, Fusarium, Scedosporium, and Mucorales pose serious challenges, especially in immunocompromised and oncology patients. Accurate antifungal susceptibility testing (AFST) is essential for guiding therapy and monitoring resistance trends. The EUCAST (European Committee on Antimicrobial Susceptibility Testing) broth microdilution method is a standardized and reference procedure for determining the minimum inhibitory concentration (MIC) of antifungal agents against molds. It provides reproducible, quantitative, and clinically relevant data essential for antifungal stewardship.

Principle

The EUCAST broth microdilution method determines antifungal susceptibility by exposing molds to serial dilutions of antifungal drugs in a defined liquid medium (RPMI 1640 with glucose). Conidial suspensions are standardized and inoculated into 96-well microdilution plates containing known antifungal concentrations. Plates are incubated at 35 °C for 48–72 hours (depending on the growth rate of the mold). The MIC is read as the lowest concentration of antifungal that visibly inhibits fungal growth compared with the growth control. EUCAST guidelines (E.DEF 9.3.2) specify technical parameters, quality controls, and interpretive breakpoints to ensure standardization across laboratories.

Clinical Significance

1. Guides Antifungal Therapy – Helps clinicians select the most effective antifungal based on MIC values.
2. Detects Resistance – Identifies resistance to azoles, echinocandins, and amphotericin B in molds like Aspergillus fumigatus.
3. Epidemiological Surveillance – Tracks antifungal resistance trends globally for public health and clinical decision-making.
4. Research and Quality Control – Serves as a reference method for evaluating new antifungal compounds.
5. Clinical Correlation – MIC data assist in distinguishing susceptible vs. resistant isolates, supporting targeted treatment.

Comparison: EUCAST vs CLSI vs E-Test for Mold Antifungal Susceptibility Testing

Parameter	EUCAST (Europe)	CLSI (USA)	E-Test (Commercial Gradient Method)
Full Form	European Committee on Antimicrobial Susceptibility Testing	Clinical and Laboratory Standards Institute	Epsilometer Test (bioMérieux)
Reference Document	E.DEF 9.3.2 (latest version for molds)	M38-A3 (latest CLSI guideline)	Manufacturer instructions
Principle	Broth microdilution in 96-well plates using RPMI 1640 medium (pH 7.0, 2% glucose)	Broth microdilution using RPMI 1640 (pH 7.0, 0.2% glucose)	Antifungal gradient diffusion on agar surface
Endpoint Reading	100% inhibition (complete growth inhibition)	50% inhibition for azoles and echinocandins (visual or spectrophotometric)	Point of intersection of elliptical inhibition zone with E-strip scale
Incubation Temperature	35°C ± 2°C	35°C ± 2°C	35°C ± 2°C
Incubation Time	48–72 hours depending on mold growth rate	48–72 hours depending on species	24–72 hours (variable)
Inoculum Standardization	2–5 × 10⁵ conidia/mL (precisely adjusted)	0.4–5 × 10⁴ CFU/mL	0.5 McFarland equivalent inoculum suspension
Reading Method	Visual or spectrophotometric (OD at 530 nm)	Visual reading (manual)	Visual reading of elliptical inhibition zone
Interpretive Criteria	EUCAST Clinical Breakpoints (CBPs) and ECOFFs	CLSI Clinical Breakpoints and ECVs	Relies on EUCAST/CLSI for interpretation
Quality Control Strains	A. fumigatus ATCC 204305, A. flavus ATCC 204304	A. fumigatus ATCC MYA-3626, A. flavus ATCC 204304	Same QC strains as EUCAST/CLSI
Common Antifungals Tested	Amphotericin B, azoles, echinocandins, isavuconazole	Amphotericin B, azoles, echinocandins	Same antifungals in gradient form
Advantages	Highly standardized, reproducible, quantitative, used globally in Europe	Gold standard in North America, validated clinically	Simple, easy to perform, no special equipment
Limitations	Labor-intensive, requires precise inoculum prep	Time-consuming, manual reading subjectivity	Costly per strip, less reproducible for molds
Best Use	Reference labs, research centers, EU surveillance studies	Clinical and research mycology labs	Routine hospital labs and teaching settings
Output	MIC value (µg/mL) with interpretive category (S/I/R)	MIC value (µg/mL) with interpretive category	MIC value (µg/mL) visually derived

Keynotes

• EUCAST broth microdilution is a quantitative reference method for mold antifungal susceptibility testing.
• Common antifungals tested: amphotericin B, itraconazole, voriconazole, posaconazole, isavuconazole, and echinocandins.
• Endpoints: Determined by visual reading or spectrophotometric comparison of growth inhibition.
• Advantages: High reproducibility, standardized conditions, and clinically correlated breakpoints.
• Limitations: Labor-intensive, requires technical expertise, and is not ideal for routine, high-throughput testing.
• Applications: Clinical diagnostics, resistance surveillance, antifungal development, and validation of automated systems.
• Plays a crucial role in managing emerging antifungal resistance in molds, particularly azole-resistant Aspergillus fumigatus.
• EUCAST and CLSI methods are reference standards for antifungal susceptibility testing of molds.
• E-Test is a practical, semi-quantitative alternative used when microdilution systems are not available.
• EUCAST provides quantitative and harmonized guidelines widely adopted in Europe and global research settings.
• CLSI remains the U.S. reference method, often used for regulatory and clinical validation.

Further Readings

• https://www.clinicalmicrobiologyandinfection.org/article/S1198-743X(14)61011-9/fulltext
• https://www.mdpi.com/2309-608X/10/3/214
• https://www.uptodate.com/contents/antifungal-susceptibility-testing
• https://pmc.ncbi.nlm.nih.gov/articles/PMC7194854/
• https://www.mdpi.com/2309-608X/10/3/214
• https://www.researchgate.net/profile/Maiken_Cavling_Arendrup/publication/242279976_EUCAST_DEFINITIVE_DOCUMENT_EDEF_91_Method_for_the_determination_of_broth_dilution_minimum_inhibitory_concentrations_of_antifungal_agents_for_conidia_forming_moulds/links/00463528b432935636000000.pdf
• https://journals.asm.org/doi/10.1128/jcm.02432-10
• https://pmc.ncbi.nlm.nih.gov/articles/PMC10971485/
• https://onlinelibrary.wiley.com/doi/10.1111/j.1469-0691.2008.02086.